Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis

@inproceedings{Huang2014UseOV,
  title={Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis},
  author={Yue Huang and Sarah A. Lewis and J Robert Britton},
  booktitle={BMC public health},
  year={2014}
}
BACKGROUND Varenicline is probably the most effective smoking cessation pharmacotherapy, but is less widely used than nicotine replacement therapy. We therefore set out to identify the characteristics of numerically important groups of patients who typically do, or do not, receive varenicline in the UK. METHODS We used association rule mining to analyse data on prescribing of smoking cessation pharmacotherapy in relation to age, sex, comorbidity and other variables from 477,620 people aged 16… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
11 Extracted Citations
15 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 11 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 15 references

and Drug Administration (FDA): Information for Healthcare Professionals: Varenicline (marked as Chantix) and Bupropion (marked as Zyban, Wellbutrin, and generics)

  • U. S. Foo
  • 2009. http://www.fda.gov/Safety/ MedWatch…
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…